Detecting HPV mRNA to assess cervical cancer risk in low-resource areas
Human papillomavirus mRNA detection for assessing cervical cancer risk in resource-limited settings
This study is working on a new, easy, and affordable test to quickly detect high-risk HPV, which can lead to cervical cancer, especially in places that don’t have access to regular screenings, so that women can get the help they need sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rice University NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10990166 on NIH RePORTER |
What this research studies
This research focuses on developing a new method for detecting high-risk human papillomavirus (hrHPV) mRNA, which is linked to cervical cancer risk. The approach aims to create a simple, cost-effective test that can be used in resource-limited settings where traditional screening methods are not available. By using both provider and self-collected cervical samples, the test will amplify hrHPV mRNA and provide real-time results with minimal user steps. This innovative method seeks to improve early detection and treatment of cervical cancer in underserved populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are women in low-resource settings who are at risk for cervical cancer due to hrHPV.
Not a fit: Patients who are not at risk for cervical cancer or those in high-resource settings may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cervical cancer screenings, reducing incidence and mortality rates in low-resource settings.
How similar studies have performed: Previous research has shown that detecting hrHPV mRNA can be a more specific biomarker for cervical cancer risk, indicating potential success for this novel approach.
Where this research is happening
Houston, United States
- Rice University — Houston, United States (Active)
Researchers
- Principal investigator: Novak, Emilie Newsham — Rice University
- Study coordinator: Novak, Emilie Newsham
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.